Isox-Cha-Chg-ARK(Sulfo-Cy5)-NH2
Isox-Cha-Chg-ARK(Sulfo-Cy5)-NH2
SMILES |
C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC1CCCCC1)NC(=O)C2=CC=NO2)C3=CC=CC=C3)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCNC(=O)CCCCC[N+]4=C(/C=C/C=C/C=C\5/N(C)C6=C(C=C(C=C6)S([O-])(=O)=O)C5(C)C)C(C)(C)C7=C4C=CC(=C7)S([O-])(=O)=O)C(N)=O |
InChIKey |
VXLISXCVTHKWNE-XZFSOASESA-M |
Sequence |
None |
Chemical Properties
Hydrogen bond acceptors |
None |
Hydrogen bond donors |
None |
Rotatable bonds |
None |
Molecular weight (Da) |
|
Bioactivities
|
Receptor |
Activity |
Source |
Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
|
Receptor |
Activity |
Source |
Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
Isox-Cha-Chg-ARK(Sulfo-Cy5)-NH2
Drug properties
Molecular type |
Peptide |
Physiological/Surrogate |
Surrogate |
Approved drug |
No |
Clinical Trials
Phase I
0
Phase II
0
Phase III
0
Approved
No
Sankey plot
Compound is not listed as a drug.